TY - JOUR
T1 - Complete global myocardial ischemia in dogs
AU - Jennings, R. B.
AU - Reimer, K. A.
AU - Steenbergen, C.
PY - 1988
Y1 - 1988
N2 - Complete global myocardial ischemia or zero coronary arterial flow in dogs results in a series of well-defined changes which begin when the myocardium converts from aerobic to anaerobic metabolism. These processes continue until the myocardium dies. The products of anaerobic metabolism, chiefly glycolytic intermediates, inorganic phosphate, H+, and creatine, are prodcued intracellularly and accumulate in the tissue. Because the demand for high-energy phosphates (HEP) in the tissue exceeds the supply available from anaerobic glycolysis and HEP reserves, net ATP level declines, approaching zero after 100 min of ischemia at 37°C. At this time, the changes in totally ischemic tissue in vitro are equivalent to those seen in myocytes irreversibly injured by severe ischemia in vivo. During reoxygenation after total ischemia, the resumption of effective contractile activity depends partly on the metabolic changes and degree of myocyte injury sustained during ischemia.
AB - Complete global myocardial ischemia or zero coronary arterial flow in dogs results in a series of well-defined changes which begin when the myocardium converts from aerobic to anaerobic metabolism. These processes continue until the myocardium dies. The products of anaerobic metabolism, chiefly glycolytic intermediates, inorganic phosphate, H+, and creatine, are prodcued intracellularly and accumulate in the tissue. Because the demand for high-energy phosphates (HEP) in the tissue exceeds the supply available from anaerobic glycolysis and HEP reserves, net ATP level declines, approaching zero after 100 min of ischemia at 37°C. At this time, the changes in totally ischemic tissue in vitro are equivalent to those seen in myocytes irreversibly injured by severe ischemia in vivo. During reoxygenation after total ischemia, the resumption of effective contractile activity depends partly on the metabolic changes and degree of myocyte injury sustained during ischemia.
UR - http://www.scopus.com/inward/record.url?scp=0023687357&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023687357&partnerID=8YFLogxK
U2 - 10.1097/00003246-198810000-00010
DO - 10.1097/00003246-198810000-00010
M3 - Review article
C2 - 3048898
AN - SCOPUS:0023687357
SN - 0090-3493
VL - 16
SP - 988
EP - 996
JO - Critical care medicine
JF - Critical care medicine
IS - 10
ER -